HYFM vs. CRSP

Last updated Jun 23, 2026

HYFM (Hydrofarm Holdings Group, Inc.) and CRSP (CRISPR Therapeutics AG) are both stocks. HYFM operates in Farm & Heavy Construction Machinery (Industrials), while CRSP operates in Biotechnology (Healthcare). Over the past 5 years, HYFM returned -72.23%/yr vs -16.09%/yr for CRSP. At a 0.32 correlation, their price movements are largely independent.

Performance

HYFM vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hydrofarm Holdings Group, Inc. (HYFM) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HYFM achieves a -39.85% return, which is significantly lower than CRSP's 3.66% return.

HYFM

• 1D: 1.93%
• 1M: -6.51%
• YTD: -39.85%
• 6M: -48.10%
• 1Y: -75.81%
• 3Y*: -54.08%
• 5Y*: -72.23%
• 10Y*: —

CRSP

• 1D: 0.50%
• 1M: 7.94%
• YTD: 3.66%
• 6M: -6.13%
• 1Y: 22.85%
• 3Y*: -1.00%
• 5Y*: -16.09%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HYFM vs. CRSP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
HYFM Hydrofarm Holdings Group, Inc.	-39.85%	-73.97%	-36.78%	-40.81%	-94.52%	-46.20%	14.30%
CRSP CRISPR Therapeutics AG	3.66%	33.23%	-37.12%	54.00%	-46.36%	-50.51%	4.42%

Correlation

The correlation between HYFM and CRSP is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.31
Correlation (All Time) Calculated using the full available price history since Dec 10, 2020	0.32

The correlation between HYFM and CRSP shifts across timeframes, from 0.14 (1 year) to 0.32 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap HYFM : $4.33M CRSP : $5.22B
EPS HYFM : -$61.90 CRSP : -$6.24
PS Ratio HYFM : 0.03 CRSP : 1.21K
Total Revenue (TTM) HYFM : $122.24M CRSP : $4.10M
Gross Profit (TTM) HYFM : $10.17M CRSP : -$171.17M
EBITDA (TTM) HYFM : -$21.47M CRSP : -$509.21M

Return for Risk

HYFM vs. CRSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HYFM

HYFM Risk / Return Rank: 8
HYFM Sharpe Ratio Rank: 10
HYFM Sortino Ratio Rank: 7
HYFM Omega Ratio Rank: 8
HYFM Calmar Ratio Rank: 6
HYFM Martin Ratio Rank: 11

CRSP

CRSP Risk / Return Rank: 54
CRSP Sharpe Ratio Rank: 55
CRSP Sortino Ratio Rank: 56
CRSP Omega Ratio Rank: 52
CRSP Calmar Ratio Rank: 55
CRSP Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HYFM vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hydrofarm Holdings Group, Inc. (HYFM) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HYFM	CRSP	Difference
Sharpe ratio: Return per unit of total volatility	-0.76	0.37	-1.13
Sortino ratio: Return per unit of downside risk	-1.40	0.99	-2.39
Omega ratio: Gain probability vs. loss probability	0.83	1.11	-0.28
Calmar ratio: Return relative to maximum drawdown	-0.91	0.54	-1.46
Martin ratio: Return relative to average drawdown	-1.31	0.89	-2.19

HYFM vs. CRSP - Sharpe Ratio Comparison

The current HYFM Sharpe Ratio is -0.76, which is lower than the CRSP Sharpe Ratio of 0.37. The chart below compares the historical Sharpe Ratios of HYFM and CRSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

HYFM vs. CRSP - Drawdown Comparison

The maximum HYFM drawdown since its inception was -99.92%, which is greater than CRSP's maximum drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for HYFM and CRSP.

Drawdown Indicators

	HYFM	CRSP	Difference
Max Drawdown Largest peak-to-trough decline	-99.92%	-85.11%	-14.81%
Max Drawdown (1Y) Largest decline over 1 year	-83.04%	-42.25%	-40.79%
Max Drawdown (3Y) Largest decline over 3 years	-95.07%	-64.91%	-30.16%
Max Drawdown (5Y) Largest decline over 5 years	-99.87%	-80.68%	-19.19%
Current Drawdown Current decline from peak	-99.90%	-74.12%	-25.78%
Average Drawdown Average peak-to-trough decline	-86.32%	-49.29%	-37.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	57.94%	25.88%	+32.06%

Volatility

HYFM vs. CRSP - Volatility Comparison

The current volatility for Hydrofarm Holdings Group, Inc. (HYFM) is 13.37%, while CRISPR Therapeutics AG (CRSP) has a volatility of 17.92%. This indicates that HYFM experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HYFM	CRSP	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.37%	17.92%	-4.55%
Volatility (6M) Calculated over the trailing 6-month period	66.10%	43.95%	+22.15%
Volatility (1Y) Calculated over the trailing 1-year period	99.87%	62.70%	+37.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	94.73%	60.72%	+34.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	94.42%	64.31%	+30.11%

Dividends

HYFM vs. CRSP - Dividend Comparison

Neither HYFM nor CRSP has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both HYFM and CRSP in my portfolio?

HYFM and CRSP have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HYFM or CRSP?

CRSP has higher volatility (17.92%) compared to HYFM (13.37%). In terms of maximum drawdown, HYFM dropped -99.92% vs CRSP's -85.11%.

Which has better risk-adjusted returns?

CRSP currently has the higher Sharpe Ratio (0.37 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.